Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT01705080
Registration number
NCT01705080
Ethics application status
Date submitted
19/09/2012
Date registered
12/10/2012
Titles & IDs
Public title
IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN
Query!
Scientific title
IntErnational Non-randomized, Single-arm, Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN
Query!
Secondary ID [1]
0
0
1201
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
EnligHTN-II
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Hypertension
0
0
Query!
Blood Pressure
0
0
Query!
Condition category
Condition code
Cardiovascular
0
0
0
0
Query!
Hypertension
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Treatment: Devices - EnligHTN
A - EnligHTN for Severe Resistant HTN - * Office systolic Blood Pressure =160 mmHg
* Subject is taking =3 anti-hypertensive medications (including 1 diuretic), or subject has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs.
* Patient has an estimated GFR =45 mL/min per 1.73 m\^2 using the Modification of Diet in Renal Disease (MDRD) formula
B - EnligHTN for Resistant HTN - * Office systolic Blood Pressure =140 mmHg
* Subject is taking =3 anti-hypertensive medications (including 1 diuretic), or subject has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs.
* Patient has an estimated GFR =45 mL/min per 1.73 m\^2 using the Modification of Diet in Renal Disease (MDRD) formula
C - EnligHTN for Resistant HTN & CKD - * Office systolic Blood Pressure =140 mmHg
* Subject is taking =3 anti-hypertensive medications (including 1 diuretic), or subject has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs.
* Patient has an estimated =15 GFR \<45 mL/min per 1.73 m\^2 using the Modification of Diet in Renal Disease (MDRD) formula
Treatment: Devices: EnligHTN
Renal artery ablation with EnligHTN system used for all groups
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Mean Reduction in Office Systolic Blood Pressure From Baseline to 6 Months
Query!
Assessment method [1]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [1]
0
0
Baseline to 6 months
Query!
Secondary outcome [1]
0
0
Acute Safety: Percentage of Participants With Peri-procedural Events Within 30 Days Post-procedure
Query!
Assessment method [1]
0
0
The peri-procedural events occurring within 30 days post procedure were summarized as the percentage of the number of participants with peri-procedural events within 30 days post procedure compared to the number of participants at baseline for that population.
Query!
Timepoint [1]
0
0
30 days post procedure
Query!
Secondary outcome [2]
0
0
Midterm Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 6 Months
Query!
Assessment method [2]
0
0
The new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per Renal Artery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed on the time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.
Query!
Timepoint [2]
0
0
6 months
Query!
Secondary outcome [3]
0
0
Midterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 Months
Query!
Assessment method [3]
0
0
Renal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.
Query!
Timepoint [3]
0
0
Confirmatory visit to 6 months
Query!
Secondary outcome [4]
0
0
Long Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 2 Years
Query!
Assessment method [4]
0
0
The new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per RenalArtery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed onthe time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.
Query!
Timepoint [4]
0
0
2 years
Query!
Secondary outcome [5]
0
0
Long Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 5 Years
Query!
Assessment method [5]
0
0
The new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per RenalArtery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed onthe time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.
Query!
Timepoint [5]
0
0
5 years
Query!
Secondary outcome [6]
0
0
Long Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 Years
Query!
Assessment method [6]
0
0
Renal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.
Query!
Timepoint [6]
0
0
Confirmatory visit to 2 years
Query!
Secondary outcome [7]
0
0
Long Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 Years
Query!
Assessment method [7]
0
0
Renal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.
Query!
Timepoint [7]
0
0
Confirmatory visit to 5 years
Query!
Secondary outcome [8]
0
0
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 Months
Query!
Assessment method [8]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [8]
0
0
Baseline to 6 months
Query!
Secondary outcome [9]
0
0
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 Months
Query!
Assessment method [9]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [9]
0
0
Baseline to 6 months
Query!
Secondary outcome [10]
0
0
Mean Change in Office Diastolic Blood Pressure From Baseline to 6 Months
Query!
Assessment method [10]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [10]
0
0
Baseline to 6 months
Query!
Secondary outcome [11]
0
0
Percentage of Participants Achieved Office Systolic Blood Pressure < 140 mmHg at 6 Months
Query!
Assessment method [11]
0
0
The percentage of participants achieved office systolic blood pressure \<140 mmHg at 6 months visit was computed as the percentage of the ratio of number of participants who achievied office systolic blood pressure \<140 mmHg at 6 months visit to the number of participants with data available in 6 months visit.
Query!
Timepoint [11]
0
0
6 months
Query!
Secondary outcome [12]
0
0
Mean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post Denervation
Query!
Assessment method [12]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [12]
0
0
Baseline to 1 year
Query!
Secondary outcome [13]
0
0
Mean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post Denervation
Query!
Assessment method [13]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [13]
0
0
Baseline to 2 years
Query!
Secondary outcome [14]
0
0
Mean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post Denervation
Query!
Assessment method [14]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [14]
0
0
Baseline to 3 years
Query!
Secondary outcome [15]
0
0
Mean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post Denervation
Query!
Assessment method [15]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [15]
0
0
Baseline to 4 years
Query!
Secondary outcome [16]
0
0
Mean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post Denervation
Query!
Assessment method [16]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [16]
0
0
Baseline to 5 years
Query!
Secondary outcome [17]
0
0
Mean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post Denervation
Query!
Assessment method [17]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [17]
0
0
Baseline to 1 year
Query!
Secondary outcome [18]
0
0
Mean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post Denervation
Query!
Assessment method [18]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [18]
0
0
Baseline to 2 years
Query!
Secondary outcome [19]
0
0
Mean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post Denervation
Query!
Assessment method [19]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [19]
0
0
Baseline to 3 years
Query!
Secondary outcome [20]
0
0
Mean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post Denervation
Query!
Assessment method [20]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [20]
0
0
Baseline to 4 years
Query!
Secondary outcome [21]
0
0
Mean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post Denervation
Query!
Assessment method [21]
0
0
Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Query!
Timepoint [21]
0
0
Baseline to 5 years
Query!
Secondary outcome [22]
0
0
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post Denervation
Query!
Assessment method [22]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [22]
0
0
Baseline to 1 year
Query!
Secondary outcome [23]
0
0
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post Denervation
Query!
Assessment method [23]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [23]
0
0
Baseline to 2 years
Query!
Secondary outcome [24]
0
0
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post Denervation
Query!
Assessment method [24]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [24]
0
0
Baseline to 3 years
Query!
Secondary outcome [25]
0
0
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post Denervation
Query!
Assessment method [25]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [25]
0
0
Baseline to 4 years
Query!
Secondary outcome [26]
0
0
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post Denervation
Query!
Assessment method [26]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [26]
0
0
Baseline to 5 years
Query!
Secondary outcome [27]
0
0
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post Denervation
Query!
Assessment method [27]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [27]
0
0
Baseline to 1 year
Query!
Secondary outcome [28]
0
0
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post Denervation
Query!
Assessment method [28]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [28]
0
0
Baseline to 2 years
Query!
Secondary outcome [29]
0
0
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post Denervation
Query!
Assessment method [29]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [29]
0
0
Baseline to 3 years
Query!
Secondary outcome [30]
0
0
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post Denervation
Query!
Assessment method [30]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [30]
0
0
Baseline to 4 years
Query!
Secondary outcome [31]
0
0
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post Denervation
Query!
Assessment method [31]
0
0
24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Query!
Timepoint [31]
0
0
Baseline to 5 years
Query!
Eligibility
Key inclusion criteria
* Subject is = 18 years of age at time of consent
* Subject must be able and willing to provide written informed consent
* Subject must be able and willing to comply with the required follow-up schedule
* Subject has office Systolic Blood Pressure = 140 mmHg at confirmatory visit
* Subject has a daytime mean Systolic Ambulatory Blood Pressure > 135 mmHg within 90 days prior to procedure
* Subject has established hypertension (diagnosed =12 month prior to baseline) and is on a guideline based drug regimen at a stable and fully tolerated dose consisting of = 3 anti-hypertensive medications (including 1 diuretic) or subject has a documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Subject has significant renovascular abnormalities such as renal artery stenosis > 30%
* Subject has undergone prior renal angioplasty, renal denervation, indwelling renal stents, and/or abdominal aortic stent grafts
* Subject has hemodynamically significant valvular heart disease as determined by study investigator
* Subject has a life expectancy less than 12 months, as determined by the Investigator
* Subject is participating in another clinical study which has the potential to impact their hypertension management (pharmaceutical/device/homeopathic)
* Subject is pregnant, nursing, or of childbearing potential and is not using adequate contraceptive methods
* Subject has active systemic infection
* Subject has renal arteries with diameter(s) < 4 mm in diameter
* Subject has an estimated GFR <15 mL/min per 1.73 m^2 using the MDRD formula
* Subject had a renal transplant or is awaiting a renal transplant
* Subject has blood clotting abnormalities
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Stopped early
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
17/01/2013
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
27/11/2019
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
276
Query!
Recruitment in Australia
Recruitment state(s)
SA
Query!
Recruitment hospital [1]
0
0
Royal Adelaide Hospital - Adelaide
Query!
Recruitment hospital [2]
0
0
The Prince Charles Hospital - Chermside
Query!
Recruitment hospital [3]
0
0
Royal Melbourne Hospital - City Campus - Parkville
Query!
Recruitment hospital [4]
0
0
Royal Perth Hospital - Perth
Query!
Recruitment postcode(s) [1]
0
0
5000 - Adelaide
Query!
Recruitment postcode(s) [2]
0
0
4032 - Chermside
Query!
Recruitment postcode(s) [3]
0
0
3050 - Parkville
Query!
Recruitment postcode(s) [4]
0
0
6000 - Perth
Query!
Recruitment outside Australia
Country [1]
0
0
France
Query!
State/province [1]
0
0
Franche-Comte
Query!
Country [2]
0
0
France
Query!
State/province [2]
0
0
Massy
Query!
Country [3]
0
0
France
Query!
State/province [3]
0
0
Lyon
Query!
Country [4]
0
0
France
Query!
State/province [4]
0
0
St. Etienne
Query!
Country [5]
0
0
France
Query!
State/province [5]
0
0
Strasbourg
Query!
Country [6]
0
0
Germany
Query!
State/province [6]
0
0
Bavaria
Query!
Country [7]
0
0
Germany
Query!
State/province [7]
0
0
Hesse
Query!
Country [8]
0
0
Germany
Query!
State/province [8]
0
0
Nordrhein Westfalen
Query!
Country [9]
0
0
Germany
Query!
State/province [9]
0
0
Saxony
Query!
Country [10]
0
0
Germany
Query!
State/province [10]
0
0
Bad Krozingen
Query!
Country [11]
0
0
Germany
Query!
State/province [11]
0
0
Berlin
Query!
Country [12]
0
0
Germany
Query!
State/province [12]
0
0
Essen
Query!
Country [13]
0
0
Germany
Query!
State/province [13]
0
0
Homburg
Query!
Country [14]
0
0
Germany
Query!
State/province [14]
0
0
Mainz
Query!
Country [15]
0
0
Germany
Query!
State/province [15]
0
0
Trier
Query!
Country [16]
0
0
Greece
Query!
State/province [16]
0
0
Athens
Query!
Country [17]
0
0
Italy
Query!
State/province [17]
0
0
Tuscany
Query!
Country [18]
0
0
Italy
Query!
State/province [18]
0
0
Bologna
Query!
Country [19]
0
0
Italy
Query!
State/province [19]
0
0
Milano
Query!
Country [20]
0
0
Netherlands
Query!
State/province [20]
0
0
Den Haag
Query!
Country [21]
0
0
Netherlands
Query!
State/province [21]
0
0
Utrecht
Query!
Country [22]
0
0
New Zealand
Query!
State/province [22]
0
0
Dunedin
Query!
Country [23]
0
0
Norway
Query!
State/province [23]
0
0
Bergen
Query!
Country [24]
0
0
Norway
Query!
State/province [24]
0
0
Trondheim
Query!
Country [25]
0
0
Spain
Query!
State/province [25]
0
0
Basque
Query!
Country [26]
0
0
Sweden
Query!
State/province [26]
0
0
Goteborg
Query!
Country [27]
0
0
United Kingdom
Query!
State/province [27]
0
0
London
Query!
Country [28]
0
0
United Kingdom
Query!
State/province [28]
0
0
Sheffield
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Abbott Medical Devices
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The purpose of this post market clinical investigation is to further evaluate the safety and performance of the EnligHTN™ Renal Denervation System in the treatment of patients with uncontrolled hypertension.
Query!
Trial website
https://clinicaltrials.gov/study/NCT01705080
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Melvin Lobo, MBChB PhD
Query!
Address
0
0
NIHR Barts Cardiovascular Biomedical Research Unit
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Type
Other Details
Attachment
Study protocol
Study Protocol, Statistical Analysis Plan, and Inf...
[
More Details
]
https://cdn.clinicaltrials.gov/large-docs/80/NCT01705080/Prot_SAP_ICF_000.pdf
Statistical analysis plan
Study Protocol, Statistical Analysis Plan, and Inf...
[
More Details
]
https://cdn.clinicaltrials.gov/large-docs/80/NCT01705080/Prot_SAP_ICF_000.pdf
Informed consent form
Study Protocol, Statistical Analysis Plan, and Inf...
[
More Details
]
https://cdn.clinicaltrials.gov/large-docs/80/NCT01705080/Prot_SAP_ICF_000.pdf
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results are available at
https://clinicaltrials.gov/study/NCT01705080